查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球製藥乾燥設備市場：按類型、營運規模、最終用戶、地區分類 - 預測至 2029 年
市場調查報告書
商品編碼
1580575

全球製藥乾燥設備市場：按類型、營運規模、最終用戶、地區分類 - 預測至 2029 年

Pharmaceutical Drying Equipment Market by Type (Freeze, Spray, Vacuum, Fluidized Bed), Scale of Operation (Industrial-scale, Pilot-scale, Lab-scale), End User (Pharmaceutical Companies, CDMOs, Research Universities) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 227 Pages | 訂單完成後即時交付

價格

全球製藥乾燥設備市場規模預計將從 2024 年的 58 億美元增至 2029 年的 81.8 億美元，預測期內複合年成長率為 7.1%。

這是因為糖尿病、心血管疾病和癌症等慢性疾病的盛行率不斷上升，導致對藥物的需求增加。為了滿足對藥品不斷成長的需求，藥品生產設施不斷擴建，從而導致製藥設備乾燥機的需求增加。然而，製藥業對再生式乾燥機的需求不斷增加是市場的主要限制因素。此外，藥品乾燥設備的高維護成本是市場成長的主要挑戰。然而，由於各種藥品的市場獨佔性喪失和新興市場的高成長潛力，藥品製造業的競爭日益激烈，這預計將在 2024-2029 年預測期內對藥品乾燥設備市場的參與企業有利。的成長機會。

調查範圍
調查年份 2024-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元/十億美元）
按細分市場 按類型、營運規模、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

按類型分類，噴霧乾燥機領域預計將在預測期內佔據製藥乾燥設備市場的最大佔有率。原因在於它的多功能性、效率以及提高產品品質的能力。噴霧乾燥機透過生產無塵、易流動且易於再分散的粉末來提高生物有效性，使其成為熱塑性、吸濕性和熱敏性產品的理想選擇。噴霧乾燥機對於維持活性藥物成分的品質至關重要。這是因為噴霧乾燥機可以處理各種類型的產品，包括顆粒狀和團聚的產品，而不會導致熱劣化。它在該領域的受歡迎程度也歸因於其體積小，這確保了節能運行，並使其成為大規模製藥生產的經濟選擇。

根據營運規模，製藥乾燥設備市場分為工業規模設備、中試規模設備和實驗室規模設備。中試規模設備產業預計將以最高的複合年成長率成長，因為它在藥物研發（R＆D）中發揮關鍵作用。隨著新藥開發的進展，中試規模設備允許製造商在大規模工業生產之前以更小、更具成本效益的規模測試配方和製程。這種實惠的價格使其成為研發過程中的理想選擇，在最佳化製造方法的同時最大限度地降低財務風險。此外，製造外包給 CDMO 的趨勢不斷成長，進一步推動了對中試規模設備的需求。 CDMO 使用這些系統來簡化從研發到大規模生產的過渡，並確保為製藥公司提供高效且可擴展的解決方案。隨著越來越多的公司依靠 CDMO 將新藥推向市場，對中試設備的需求持續成長，促進了快速成長。

本報告研究了全球製藥乾燥設備市場，並按類型、營運規模、最終用戶、地區和進入市場的公司概況總結了趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 技術分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管狀況
  • 專利分析
  • 貿易分析
  • 價格分析
  • 2024-2025年重大會議和活動
  • 未滿足的需求
  • 最終用戶的期望
  • 人工智慧/產生人工智慧對製藥乾燥設備市場的影響
  • 生態系分析
  • 案例研究分析
  • 供應鏈分析
  • 鄰近市場分析
  • 影響客戶業務的趨勢/干擾
  • 投資金籌措場景

第6章醫藥乾燥設備市場（按類型）

  • 介紹
  • 噴霧乾燥機
  • 冷凍乾燥機
  • 流體化床乾燥機
  • 真空乾燥機
  • 其他

第7章 醫藥乾燥設備市場（依經營規模）

  • 介紹
  • 產業規模
  • 中試規模設備
  • 實驗室規模

第8章製藥乾燥設備市場（按最終用戶）

  • 介紹
  • 製藥和生物技術公司
  • 藥品研究、開發和受託製造廠商
  • 學術研究所

第9章醫藥乾燥設備市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 介紹
  • 主要參與企業的策略/秘密
  • 2021-2023 年收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 企業價值評估及財務指標
  • 品牌/產品比較
  • 競爭場景

第11章 公司簡介

  • 主要參與企業
    • GEA GROUP AKTIENGESELLSCHAFT
    • IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
    • ATS CORPORATION
    • HOSOKAWA MICRON GROUP
    • FREUND CORP.
    • SYNTEGON TECHNOLOGY GMBH
    • BUCHI LABORTECHNIK AG
    • OPTIMA
    • MECHATECH SYSTEMS LTD.
    • BEW ENGINEERING
  • 其他公司
    • ZIRBUS TECHNOLOGY GMBH
    • SPX FLOW, INC.
    • EUROPEAN SPRAYDRY TECHNOLOGIES
    • YAMATO SCIENTIFIC CO., LTD.
    • SAKA
    • ILSHIN BIOBASE
    • OKAWARA MFG. CO., LTD.
    • CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.
    • BACHILLER
    • MILLROCK TECHNOLOGY, INC.
    • MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH
    • LABCONCO
    • O'HARA TECHNOLOGIES
    • COOLVACUUM TECHNOLOGIES, SL
    • SHACHI ENGINEERING PVT. LTD.

第12章附錄

Product Code: PH 2704

The global Pharmaceutical Drying Equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. This is due to growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, is leading to increase in demand for the pharmaceutical drugs. To meet this increased demand for the medicines the pharmaceutical manufacturing facilities are expanding, consequently increasing the demand for the pharmaceutical equipment dryers. However, the increased demand for the refurbished dryers in pharmaceutical industry is major restraint to the market. Additionally, Higher maintenance of the pharmaceutical drying equipment is major challenge for the market growth. But, the increasing competition in pharmaceutical manufacturing industry due to loss of various drugs' market exclusivity and high growth potential of emerging markets is expected to present profitable growth opportunities for pharmaceutical drying equipment market players over the forecast period of 2024-2029.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million/Billion)
SegmentsBy Type, Scale of Operation, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, and MEA (GCC Countries, RoMEA)

"The spray dryer segment of pharmaceutical drying market to hold largest position forecast period."

Based on the type, the spray dryer segment is anticipated to hold largest share position during forecast period in pharmaceutical drying equipment market. This is due to its versatility, efficiency, and ability to enhance product quality. It offers improved bioavailability by producing dust-free, free-flowing, and easily re-dispersible powders, making it ideal for thermoplastic, hygroscopic, and heat-sensitive products. Spray dryers are essential for maintaining quality of active pharmaceutical ingredient. As spray dryers can handle a wide variety of product types, including granulated and agglomerated forms, without heat deterioration. Its popularity in the sector is also a result of its small size, which guarantees energy-efficient operations and makes it an affordable option for large-scale pharmaceutical production.

"The pilot-scale equipment segment is the fastest growing segment in pharmaceutical drying equipment market."

Based on scale of operation, the pharmaceutical drying equipment market is segmented into industrial-scale equipment, pilot-scale equipment, and laboratory-scale equipment. The pilot-scale equipment segment is expected to grow at the highest CAGR due to its pivotal role in pharmaceutical research and development (R&D). With increasing development of new medications, pilot-scale equipment allows manufacturers to test formulations and processes on a smaller, more cost-effective scale before full-scale industrial production. This affordability makes it an ideal choice during R&D, minimizing financial risk while optimizing production methods. Additionally, the growing trend of outsourcing manufacturing to Contract Development and Manufacturing Organizations (CDMOs) has further driven the demand for pilot-scale equipment. CDMOs use these systems to streamline the transition from R&D to large-scale production, ensuring efficient and scalable solutions for pharmaceutical companies. As more companies rely on CDMOs to bring new drugs to market, the need for pilot-scale equipment continues to rise, contributing to its rapid growth.

"Europe accounted for the second largest share of the pharmaceutical drying equipment market by region."

The global pharmaceutical drying equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for pharmaceutical drying equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Europe holds the second-largest position in the pharmaceutical drying equipment market. This is due to the presence of key industry players such as GEA Group (Germany), I.M.A. Industria Macchine Automatiche (Italy), Syntegon Technology GmbH (Germany), and Mechatech Systems Ltd (UK). These major European players are making significant investments in R&D to create cutting-edge, innovative equipment. Furthermore, the European region's strong pharmaceutical manufacturing base, established regulatory framework, and focus on technological advancements all contribute to its strong market position. In Europe, the need for pharmaceutical drying equipment is being driven by innovation and industry leadership.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-50%, Director-level-30% and Others-20%
  • By Region: North America-38%, Europe-26%, Asia Pacific-15%, Latin America- 11%, and Middle East and Africa-10%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = > USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the pharmaceutical drying equipment market are GEA Group (Germany), ATS Corporation (US), Hosokawa Micron Group (Japan), Freund Corporation (Japan), I.M.A. Industria Macchine Automatiche S.p.A. (Italy), Syntegon Technology GmbH (Germany), BUCHI Labortechnik AG (Switzerland), OPTIMA packaging group GmbH (Germany), Mechatech Systems Ltd (Netherland), and BEW Engineering Limited (India).

Research Coverage

This report studies the pharmaceutical drying equipment market based on type, scale of operation,, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers (The expansion of pharmaceutical manufacturing facilities to drive market growth, The increased demand for biopharmaceuticals to drive market, The rapid growth of the contact manufacturing companies to drive market), restraints (The demand for refurbished drying equipment is restraining the market) , Challenge (Higher maintenance of the pharmaceutical drying equipment is major challenge for the market), opportunity (Increasing competition in pharmaceutical manufacturing industry due to loss of various drugs' market exclusivity, High growth potential of emerging markets)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pain management devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the pharmaceutical drying equipment market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS AND REGIONS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key objectives of secondary research
      • 2.1.1.2 Key secondary sources
      • 2.1.1.3 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key primary sources
      • 2.1.2.2 Key objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.4 DEMAND-SIDE ANALYSIS (USING PHARMACEUTICAL DRYING EQUIPMENT ADOPTION)
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PHARMACEUTICAL DRYING EQUIPMENT MARKET OVERVIEW
  • 4.2 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2023
  • 4.3 GEOGRAPHIC SNAPSHOT OF PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2024-2029
  • 4.4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGIONAL MIX, 2022-2029
  • 4.5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS, 2024 VS. 2029 (USD MILLION)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Expansion of pharmaceutical manufacturing facilities
      • 5.2.1.2 High demand for biopharmaceuticals
      • 5.2.1.3 Rapid growth of contract manufacturing and development companies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increased demand for refurbished drying equipment
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increased market competition and high demand for generic and biosimilar drugs
      • 5.2.3.2 High growth potential in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Need for regular maintenance and high associated costs
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 AUTOMATION AND DIGITALIZATION
    • 5.3.2 ENVIRONMENTAL SUSTAINABILITY
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Automation and control systems
      • 5.4.1.2 Heat transfer technology
      • 5.4.1.3 Vacuum technology
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 High-efficiency particulate air (HEPA) filtration technology
      • 5.4.2.2 Temperature control systems
      • 5.4.2.3 Desorption technology
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Moisture sensors and monitoring systems
      • 5.4.3.2 Air distribution systems
      • 5.4.3.3 Particle size analysis technology
  • 5.5 PORTER'S FIVE FORCE ANALYSIS
    • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF SUBSTITUTES
    • 5.5.5 THREAT OF NEW ENTRANTS
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.6.2 KEY BUYING CRITERIA
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY ANALYSIS
      • 5.7.1.1 North America
        • 5.7.1.1.1 US
        • 5.7.1.1.2 Canada
      • 5.7.1.2 Europe
      • 5.7.1.3 Asia Pacific
      • 5.7.1.4 Latin America
      • 5.7.1.5 Middle East & Africa
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT PUBLICATION TRENDS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
    • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 IMPORT DATA FOR HS CODE 8419
    • 5.9.2 EXPORT DATA FOR HS CODE 8419
  • 5.10 PRICING ANALYSIS
    • 5.10.1 INDICATIVE SELLING PRICE OF DRYERS, BY PRODUCT
    • 5.10.2 INDICATIVE SELLING PRICE OF DRYERS, BY REGION
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.12 UNMET NEEDS
  • 5.13 END-USER EXPECTATIONS
  • 5.14 IMPACT OF AI/GENERATIVE AI ON PHARMACEUTICAL DRYING EQUIPMENT MARKET
    • 5.14.1 KEY USE CASES
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: IMPROVED VACUUM PRESSURE TO REDUCE DRYING TIME, INCREASE QUALITY, AND SAVE PRODUCTION COSTS
    • 5.16.2 CASE STUDY 2: OPTIMIZED PARTICLE SIZE DISTRIBUTION FOR HIGH-POTENCY API PRODUCTION
    • 5.16.3 CASE STUDY 3: INNOVATIVE CONTAINMENT SOLUTIONS FOR HIGH-POTENCY APIS TO ENHANCE NUTSCHE FILTER DRYER PERFORMANCE
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 ADJACENT MARKET ANALYSIS
    • 5.18.1 SPRAY DRYING EQUIPMENT MARKET
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.20 INVESTMENT AND FUNDING SCENARIO

6 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 SPRAY DRYERS
    • 6.2.1 ABILITY TO MAINTAIN STABILITY OF THERMALLY SENSITIVE COMPOUNDS THROUGH RAPID DRYING TO PRESERVE DRUG EFFICACY
  • 6.3 FREEZE DRYERS
    • 6.3.1 RISING DEMAND FOR LYOPHILIZED PRODUCTS TO DRIVE MARKET
  • 6.4 FLUIDIZED BED DRYERS
    • 6.4.1 COST-EFFECTIVENESS AND UNIFORM DRYING TO SPUR DEMAND IN PHARMACEUTICAL MANUFACTURING FACILITIES
  • 6.5 VACUUM DRYERS
    • 6.5.1 VACUUM DRYERS TO MINIMIZE THERMAL DEGRADATION AND PROVIDE STABILITY TO HEAT-SENSITIVE MATERIALS
  • 6.6 OTHER DRYERS

7 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION

  • 7.1 INTRODUCTION
  • 7.2 INDUSTRIAL-SCALE EQUIPMENT
    • 7.2.1 RISING INVESTMENTS IN HIGH-QUALITY MANUFACTURING TO AUGMENT MARKET GROWTH
  • 7.3 PILOT-SCALE EQUIPMENT
    • 7.3.1 INCREASED PHARMACEUTICAL R&D INVESTMENTS AND FOCUS ON EFFECTIVE QUALITY CONTROL IN LARGER OPERATIONS TO DRIVE MARKET
  • 7.4 LABORATORY-SCALE EQUIPMENT
    • 7.4.1 COST-EFFECTIVENESS, EASY OPERATION, AND LOW MAINTENANCE NEEDS TO FUEL MARKET GROWTH

8 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL AND BIOTECH COMPANIES
    • 8.2.1 INCREASED INVESTMENTS FOR BETTER PRODUCTION EFFICIENCY IN PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
  • 8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
    • 8.3.1 INCREASED OUTSOURCING OF RESEARCH AND MANUFACTURING PROCESSES BY PHARMA COMPANIES TO PROPEL MARKET GROWTH
  • 8.4 RESEARCH ACADEMIES AND UNIVERSITIES
    • 8.4.1 RISING DEMAND FOR ADVANCED LABORATORY AND RESEARCH FACILITIES IN ACADEMIC SETTINGS TO DRIVE MARKET

9 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American pharmaceutical drying equipment market during forecast period
    • 9.2.3 CANADA
      • 9.2.3.1 Robust pharmaceutical sector and advancements in drug development to aid market growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Increased R&D investments by key players and technological advancements to support market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising investments in bioproduction capacities to spur market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Growing demand for biologics and biopharmaceuticals to boost market growth
    • 9.3.5 UK
      • 9.3.5.1 Increased government investments in pharmaceuticals and clinical trials to propel market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Increasing collaborations between drying equipment manufacturing companies to aid market growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Technological advancements and strategic expansions by key international players to augment market growth
    • 9.4.3 JAPAN
      • 9.4.3.1 High investments in manufacturing capabilities and increased geriatric population to aid market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing investments in manufacturing facilities to propel market growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increased popularity of CDMOs for pharmaceutical production to fuel market growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Advanced biologics sector and increased demand for biosimilars to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Burgeoning pharmaceutical industry and favorable trade agreements to propel market growth
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Expansion of pharmaceutical manufacturing companies to drive market
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
  • 10.3 REVENUE ANALYSIS, 2021-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Type footprint
      • 10.5.5.3 Scale of operation footprint
      • 10.5.5.4 End-user footprint
      • 10.5.5.5 Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 GEA GROUP AKTIENGESELLSCHAFT
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 MnM view
        • 11.1.2.3.1 Right to win
        • 11.1.2.3.2 Strategic choices
        • 11.1.2.3.3 Weaknesses and competitive threats
    • 11.1.3 ATS CORPORATION
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches
        • 11.1.3.3.2 Deals
        • 11.1.3.3.3 Expansions
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 HOSOKAWA MICRON GROUP
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 MnM view
        • 11.1.4.3.1 Right to win
        • 11.1.4.3.2 Strategic choices
        • 11.1.4.3.3 Weaknesses and competitive threats
    • 11.1.5 FREUND CORP.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
    • 11.1.6 SYNTEGON TECHNOLOGY GMBH
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Deals
    • 11.1.7 BUCHI LABORTECHNIK AG
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches
    • 11.1.8 OPTIMA
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
    • 11.1.9 MECHATECH SYSTEMS LTD.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
    • 11.1.10 BEW ENGINEERING
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 ZIRBUS TECHNOLOGY GMBH
    • 11.2.2 SPX FLOW, INC.
    • 11.2.3 EUROPEAN SPRAYDRY TECHNOLOGIES
    • 11.2.4 YAMATO SCIENTIFIC CO., LTD.
    • 11.2.5 SAKA
    • 11.2.6 ILSHIN BIOBASE
    • 11.2.7 OKAWARA MFG. CO., LTD.
    • 11.2.8 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.
    • 11.2.9 BACHILLER
    • 11.2.10 MILLROCK TECHNOLOGY, INC.
    • 11.2.11 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH
    • 11.2.12 LABCONCO
    • 11.2.13 O'HARA TECHNOLOGIES
    • 11.2.14 COOLVACUUM TECHNOLOGIES, SL
    • 11.2.15 SHACHI ENGINEERING PVT. LTD.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 CURRENCY CONVERSION RATES
  • TABLE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: STUDY ASSUMPTIONS
  • TABLE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RISK ASSESSMENT
  • TABLE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER'S FIVE FORCES
  • TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
  • TABLE 7 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LIST OF PATENTS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET, 2014-2024
  • TABLE 14 IMPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 15 EXPORT DATA FOR HS CODE 8419, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 16 INDICATIVE SELLING PRICING OF DRYERS, 2021-2023
  • TABLE 17 INDICATIVE SELLING PRICE OF DRYERS, BY REGION, 2022-2024
  • TABLE 18 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2024-DECEMBER 2025
  • TABLE 19 PHARMACEUTICAL DRYING EQUIPMENT MARKET: UNMET NEEDS
  • TABLE 20 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER EXPECTATIONS
  • TABLE 21 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 22 SPRAY DRYERS OFFERED BY KEY PLAYERS
  • TABLE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR SPRAY DRYERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 FREEZE DRYERS OFFERED BY KEY PLAYERS
  • TABLE 25 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FREEZE DRYERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 FLUIDIZED BED DRYERS OFFERED BY KEY PLAYERS
  • TABLE 27 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR FLUIDIZED BED DRYERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 VACUUM DRYERS OFFERED BY KEY PLAYERS
  • TABLE 29 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR VACUUM DRYERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR OTHER DRYERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 OTHER DRYERS OFFERED BY KEY PLAYERS
  • TABLE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR INDUSTRIAL-SCALE EQUIPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PILOT-SCALE EQUIPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR LABORATORY-SCALE EQUIPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 PHARMACEUTICAL DRYING EQUIPMENT MARKET FOR RESEARCH ACADEMIES AND UNIVERSITIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 45 US: KEY MACROINDICATORS
  • TABLE 46 US: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 47 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 48 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 49 US: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 50 CANADA: KEY MACROINDICATORS
  • TABLE 51 CANADA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 52 TOP FIVE EXPORTERS OF PHARMACEUTICAL PRODUCTS TO CANADA
  • TABLE 53 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 54 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 55 CANADA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 57 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 60 EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 61 GERMANY: KEY MACROINDICATORS
  • TABLE 62 GERMANY: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 63 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 65 GERMANY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 66 FRANCE: KEY MACROINDICATORS
  • TABLE 67 FRANCE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 68 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 70 FRANCE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 71 ITALY: KEY MACROINDICATORS
  • TABLE 72 ITALY: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 73 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 75 ITALY: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 76 UK: KEY MACROINDICATORS
  • TABLE 77 UK: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 78 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 80 UK: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 81 SPAIN: KEY MACROINDICATORS
  • TABLE 82 SPAIN: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 83 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 85 SPAIN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 86 SWITZERLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 87 POLAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 88 BELGIUM: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
  • TABLE 89 AUSTRIA: PHARMACEUTICAL PRODUCTION VALUE (USD MILLION)
  • TABLE 90 IRELAND: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 91 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 93 REST OF EUROPE: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 98 CHINA: KEY MACROINDICATORS
  • TABLE 99 CHINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 100 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 102 CHINA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 103 JAPAN: KEY MACROINDICATORS
  • TABLE 104 JAPAN: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 105 JAPAN: PHARMACEUTICAL PRODUCTION, BY DOSAGE FORM
  • TABLE 106 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 108 JAPAN: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 109 INDIA: KEY MACROINDICATORS
  • TABLE 110 INDIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 111 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 113 INDIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 114 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 115 AUSTRALIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 116 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 118 AUSTRALIA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 119 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURERS SIZE
  • TABLE 121 SOUTH KOREA: PHARMACEUTICAL PRODUCTION VALUE (USD BILLION)
  • TABLE 122 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 124 SOUTH KOREA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 125 SINGAPORE: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 126 SINGAPORE: PHARMACEUTICAL AND BIOLOGICAL PRODUCTION INDEX (2019-2023)
  • TABLE 127 MALAYSIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 128 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 130 REST OF ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 131 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 134 LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 135 BRAZIL: KEY MACROINDICATORS
  • TABLE 136 BRAZIL: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 137 BRAZIL: IMPORT VALUE OF PHARMACEUTICAL PRODUCTS (2020-2023)
  • TABLE 138 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 140 BRAZIL: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 141 MEXICO: KEY MACROINDICATORS
  • TABLE 142 MEXICO: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 143 MEXICO: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE (2020-2023)
  • TABLE 144 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 146 MEXICO: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 147 ARGENTINA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 148 ARGENTINA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 149 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 151 REST OF LATIN AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 156 UAE: GROWTH RATE OF PHARMACEUTICAL MANUFACTURING PLANT, 2010 VS. 2021
  • TABLE 157 SAUDI ARABIA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 158 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 160 GCC COUNTRIES: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 161 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INDUSTRY LANDSCAPE
  • TABLE 162 SOUTH AFRICA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 163 EGYPT: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 164 GHANA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 165 KENYA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 166 ETHIOPIA: PHARMACEUTICAL PRODUCTS IMPORT-EXPORT VALUE
  • TABLE 167 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • TABLE 169 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 170 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL DRYING EQUIPMENT MARKET
  • TABLE 171 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEGREE OF COMPETITION
  • TABLE 172 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TYPE FOOTPRINT
  • TABLE 173 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SCALE OF OPERATION FOOTPRINT
  • TABLE 174 PHARMACEUTICAL DRYING EQUIPMENT MARKET: END-USER FOOTPRINT
  • TABLE 175 PHARMACEUTICAL DRYING EQUIPMENT MARKET: REGION FOOTPRINT
  • TABLE 176 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYER
  • TABLE 177 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 178 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 179 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 180 PHARMACEUTICAL DRYING EQUIPMENT MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 181 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 182 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED
  • TABLE 183 GEA GROUP AKTIENGESELLSCHAFT: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 184 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
  • TABLE 185 IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS OFFERED
  • TABLE 186 ATS CORPORATION: COMPANY OVERVIEW
  • TABLE 187 ATS CORPORATION: PRODUCTS OFFERED
  • TABLE 188 ATS CORPORATION PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 189 ATS CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 190 ATS CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 191 HOSOKAWA MICRON GROUP: COMPANY OVERVIEW
  • TABLE 192 HOSOKAWA MICRON GROUP: PRODUCTS OFFERED
  • TABLE 193 FREUND CORP.: COMPANY OVERVIEW
  • TABLE 194 FREUND CORP.: PRODUCTS OFFERED
  • TABLE 195 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 196 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED
  • TABLE 197 SYNTEGON TECHNOLOGY GMBH: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 198 BUCHI LABORTECHNIK AG.: COMPANY OVERVIEW
  • TABLE 199 BUCHI LABORTECHNIK AG: PRODUCTS OFFERED
  • TABLE 200 BUCHI LABORTECHNIK AG: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 201 OPTIMA: COMPANY OVERVIEW
  • TABLE 202 OPTIMA: PRODUCTS OFFERED
  • TABLE 203 MECHATECH SYSTEMS LTD.: COMPANY OVERVIEW
  • TABLE 204 MECHATECH SYSTEMS LTD.: PRODUCTS OFFERED
  • TABLE 205 BEW ENGINEERING: COMPANY OVERVIEW
  • TABLE 206 BEW ENGINEERING: PRODUCTS OFFERED
  • TABLE 207 ZIRBUS TECHNOLOGY GMBH: COMPANY OVERVIEW
  • TABLE 208 SPX FLOW, INC.: COMPANY OVERVIEW
  • TABLE 209 EUROPEAN SPRAYDRY TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 210 YAMATO SCIENTIFIC CO., LTD.: COMPANY OVERVIEW
  • TABLE 211 SAKA: COMPANY OVERVIEW
  • TABLE 212 ILSHIN BIOBASE: COMPANY OVERVIEW
  • TABLE 213 OKAWARA MFG. CO., LTD.: COMPANY OVERVIEW
  • TABLE 214 CHANGZHOU CHANGJIANG DRYING EQUIPMENT CO., LTD.: COMPANY OVERVIEW
  • TABLE 215 BACHILLER: COMPANY OVERVIEW
  • TABLE 216 MILLROCK TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 217 MARTIN CHRIST GEFRIERTROCKNUNGSANLAGEN GMBH: COMPANY OVERVIEW
  • TABLE 218 LABCONCO: COMPANY OVERVIEW
  • TABLE 219 O'HARA TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 220 COOLVACUUM TECHNOLOGIES, SL: COMPANY OVERVIEW
  • TABLE 221 SHACHI ENGINEERING PVT. LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SEGMENTS AND REGIONS COVERED
  • FIGURE 2 PHARMACEUTICAL DRYING EQUIPMENT MARKET: YEARS CONSIDERED
  • FIGURE 3 PHARMACEUTICAL DRYING EQUIPMENT MARKET: RESEARCH DESIGN
  • FIGURE 4 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PRIMARY SOURCES
  • FIGURE 6 PHARMACEUTICAL DRYING EQUIPMENT MARKET: KEY DATA FROM PRIMARIES
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 9 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TOP-DOWN APPROACH
  • FIGURE 10 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 11 IMPACT OF CAGR ON DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
  • FIGURE 12 PHARMACEUTICAL DRYING EQUIPMENT MARKET: CAGR PROJECTIONS
  • FIGURE 13 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DATA TRIANGULATION
  • FIGURE 14 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PHARMACEUTICAL DRYING EQUIPMENT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 18 RISING INVESTMENT BY PHARMACEUTICAL FACILITIES TO DRIVE MARKET
  • FIGURE 19 PHARMACEUTICAL AND BIOTECH COMPANIES COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 20 INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 21 ASIA PACIFIC TO GROW AT HIGHEST GROWTH RATE FROM 2024 TO 2029
  • FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 23 PHARMACEUTICAL DRYING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 PHARMACEUTICAL DRYING EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL DRYING EQUIPMENT
  • FIGURE 26 KEY BUYING CRITERIA FOR PHARMACEUTICAL DRYING EQUIPMENT
  • FIGURE 27 NUMBER OF PATENTS PUBLISHED (JANUARY 2014-AUGUST 2024)
  • FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR PHARMACEUTICAL DRYING EQUIPMENT PATENTS (JANUARY 2014-AUGUST 2024)
  • FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL DRYING EQUIPMENT (JANUARY 2014-JULY 2024)
  • FIGURE 30 AVERAGE SELLING PRICE OF SINGLE-LIMB BREATHING CIRCUITS (2024)
  • FIGURE 31 MARKET POTENTIAL OF AI TO ENHANCE EFFICACY AND PRODUCT QUALITY
  • FIGURE 32 PHARMACEUTICAL DRYING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 33 PHARMACEUTICAL DRYING EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 34 SPRAY DRYING EQUIPMENT: MARKET OVERVIEW
  • FIGURE 35 PHARMACEUTICAL DRYING EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 36 PHARMACEUTICAL DRYING EQUIPMENT MARKET: INVESTMENT AND FUNDING SCENARIO (2020-2023)
  • FIGURE 37 PHARMACEUTICAL DRYING EQUIPMENT MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 38 NORTH AMERICA: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: PHARMACEUTICAL DRYING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS (2021-2023)
  • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • FIGURE 42 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 43 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 44 PHARMACEUTICAL DRYING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 45 EV/EBITDA OF KEY VENDORS
  • FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 47 PHARMACEUTICAL DRYING EQUIPMENT MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 48 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
  • FIGURE 49 ATS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 HOSOKAWA MICRON GROUP: COMPANY SNAPSHOT
  • FIGURE 51 FREUND CORP.: COMPANY SNAPSHOT
  • FIGURE 52 BEW ENGINEERING: COMPANY SNAPSHOT